Sophiris Bio Inc. (SPHS)

OTCMKTS: SPHS · Delayed Price · USD
0.00 0.00 (0.00%)
Jan 24, 2022 9:04 PM EST - Market closed

Total Valuation

Market Capn/a
Enterprise Valuen/a

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Sophiris Bio has 34.47 million shares outstanding. The number of shares has increased by 6.51% in one year.

Shares Outstanding34.47M
Shares Change (YoY)+6.51%
Shares Change (QoQ)+6.14%
Owned by Insiders (%)n/a
Owned by Institutions (%)0.03%
Float32.66M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ration/a
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of n/a.

Current Ratio1.79
Quick Ratio1.60
Debt / Equityn/a
Debt / EBITDA7.57
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -3.90%, which is considered low. The company has a high ROIC of 16.00%.

Return on Equity (ROE)-3.90%
Return on Assets (ROA)0.40%
Return on Capital (ROIC)16.00%
Revenue Per Employeen/a
Profits Per Employee$6,167
Employee Count6
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

. The beta is 1.93, so Sophiris Bio's price volatility has been higher than the market average.

Beta (1Y)1.93
52-Week Price Changen/a
50-Day Moving Averagen/a
200-Day Moving Average0.01
Average Volume (30 Days)n/a

Short Selling Information

Short Interest1.42M
Short % of Shares Out4.11%
Short % of Float4.34%
Short Ratio (days to cover)8.61

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-10.17M
Net Income37,000
EBITDA771,000
EBIT678,000
Earnings Per Share (EPS)$0.00
Full Income Statement

Balance Sheet

The company has $6.30 million in cash and $5.84 million in debt, giving a net cash position of $465,000 or $0.01 per share.

Cash & Cash Equivalents6.30M
Total Debt5.84M
Net Cash465,000
Net Cash Per Share$0.01
Book Value-2.76M
Book Value Per Share-0.08
Working Capital3.09M
Full Balance Sheet

Cash Flow

Operating Cash Flow-10.54M
Capital Expendituresn/a
Free Cash Flow-10.54M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Sophiris Bio does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yieldn/a
FCF Yieldn/a
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on August 15, 2013. It was a reverse split with a ratio of 1:52.

Last Split DateAug 15, 2013
Split TypeReverse
Split Ratio1:52